Conclusions: Towards High-Performance and Industrially Sustainable Tissue Engineering Products
Since the early 1990s, the research in biomedical field has been dominated by a paradigm shift whereby the concept of replacing damaged tissues and organs with medical devices has been overcome by the goal of their partial or complete regeneration. Although traditional implants (i.e., orthopedic, dental, cardiovascular, and ocular) are still widely used to ameliorate and save patients’ life, it is now possible to engineer materials, bioactive components, and cells able to stimulate the regeneration of tissues damaged by either disease or trauma (Sipe 2002). It has to be outlined that this paradigm shift neither emerged independently nor aims to supersede completely the traditional tissue replacement by implants or by pharmaceutical therapies. Rather, lessons have been learnt from the development of traditional implants and drugs which can now be integrated in the development of new strategies for regenerative medicine.
This chapter summarizes the principal aspects of...
KeywordsTissue Engineering Hepatocyte Growth Factor Tissue Regeneration Regenerative Medicine Compound Annual Growth Rate
The author is grateful to Mr. Mike Helias for its scanning electron microscopy technical support and to Dr. Steve Meikle for providing the chemical structures.
- Freitas RA Jr, (2005) What is nanomedicine? Nanomedicine 1:2–9Google Scholar
- Heller M, Wei C (2006) Self-assembly peptide prevents blood loss Nanomedicine 2:216Google Scholar
- Ikada Y (2007) Challenges in tissue engineering. J Roy Soc Interface 4:589–601Google Scholar
- Illsley M, James E, James S, Santin M (2007) The dose-dependant increase in alkaline phosphatase activation in response to the phytoestrogen genistein in cultured multipotent mesenchymal stromal cells. Proceedings of the 21st European Society for Biomaterials Conference.Google Scholar
- Leu HJ, Feigl W, Susani M, Odermatt B (1988) Differentiation of mononuclear blood cells into macrophages, fibroblasts and endothelial cells in thrombus organization. Exp Cell Biol 56:201–210Google Scholar
- Li K, Chuen CKY, Lee SM, Law P, Fok TF, Ng PC, Li CK, Wong D, Merzouk A, Salari H, Gu GJS, Yuen PMP (2006) Small peptide analogue of SDF-1 alpha supports survival of cord blood CD34(+) cells in synergy with other cytokines and enhances their ex vivo expansion and engraftment into nonobese diabetic/severe combined immunodeficient mice. Stem Cells 24:55–64CrossRefGoogle Scholar
- Middleton E, Kandaswami C, Theoharides TC (2000) The effect of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 52:673–751Google Scholar
- Monaghan S. (2001) Solid-phase synthesis of peptide-dendrimer conjugates for an investigation of integrin binding. ARKIVOC 46–53Google Scholar
- Morris C, Thorpe J, Ambrosio L, Santin M (2006) The soybean isoflavone genistein induces differentiation of MG63 human osteosarcoma osteoblasts. J Nutr 136:1–5Google Scholar
- Santin M, Ambrosio L (2008) Soybean-based biomaterials: preparation methods, physico-chemical properties and tissue regeneration potential. Exp Rev Med Dev, 53: 349–358.Google Scholar
- Santin M, Nicolais L, Ambrosio L (2002) Soybean-based thermoplastics as biomaterials. Patent n. WO/2002/010261Google Scholar
- Santin M, Oliver G, Standen G, Meikle S, Lloyd A (2007b) Solid Surface Functionalisation by Bi-Functional Semi-Dendrimers GB patent applicationGoogle Scholar
- Stewart H, Guildford AL, Lawrenson-Watt D, Santin M (2008) Substrate-induced phenotypical change of monocytes/macrophages into myofibroblast-like cells: a new insight into the mechanism of in-stent restenosis. J Biomed Mater Res, doi 10.1002/jbm.a.32100 Google Scholar
- Yannas IV (2007) Similarities and differences between induced organ regeneration in adults and early foetal regeneration. J Roy Soc Interface 4:403–417Google Scholar